iCo Therapeutics Inc (ICO.V) Quote| Reuters.com
Edition:
United States

iCo Therapeutics Inc (ICO.V)

ICO.V on TSX Venture Exchange

0.04CAD
30 Jun 2016
Change (% chg)

$0.00 (+16.67%)
Prev Close
$0.03
Open
$0.04
Day's High
$0.04
Day's Low
$0.04
Volume
271,000
Avg. Vol
109,846
52-wk High
$0.10
52-wk Low
$0.02

ICO.V

Chart for ICO.V

About

iCo Therapeutics Inc. (iCo) is a Canada-based biotechnology company principally focused on the identification, development and commercialization of drug candidates to treat sight-and life-threatening diseases. The Company principally focuses on in-licensing drug candidates with a clinical history, and re-dose, reformulate and... (more)

Overall

Beta: 0.95
Market Cap(Mil.): $2.96
Shares Outstanding(Mil.): 84.46
Dividend: --
Yield (%): --

Financials

  ICO.V Industry Sector
P/E (TTM): -- 42.29 36.15
EPS (TTM): -0.03 -- --
ROI: -59.84 -6.23 14.31
ROE: -59.84 -5.61 15.51

BRIEF-iCo Therapeutics Q1 loss per share c$0.01

* Ico therapeutics announces first quarter 2016 financial results

May 25 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : GlobalData
$300.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.